Evaluating A Healthcare IPO: Hedge Funds Look Beyond the Hype


  CLIENT SITUATION When Nevro, a manufacturer and distributor of a medical device to relieve back pain, announced an IPO, hedge funds sat up straight and took notice. Physicians in Europe and Australia had started to implant Nevro’s Senza HF10 System, a new high frequency spinal cord stimulator, to relieve chronic back and leg pain […]

Read More